OPY Stock Recent News
OPY LATEST HEADLINES
MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform, today announced that Eric Easom, Co-Founder, Chairman, President and CEO, will present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference. Details of the event are as follows: Oppenheimer 35th Annual Healthcare Life Sciences Conference (virtual) Eric Easom, Co-Fou.
JERUSALEM, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, announced that it will participate and be available for investor meetings at the Oppenheimer 35th Annual Healthcare Life Sciences Conference being held February 11 – 12, 2025 in a virtual format.
ENGLEWOOD, Colo. , Jan. 14, 2025 /PRNewswire/ -- XTI Aerospace, Inc. (Nasdaq: XTIA) ("XTI Aerospace" or the "Company"), a pioneer in VTOL and Powered-Lift aircraft solutions, today announced that David Oppenheimer has joined the XTI Corporate Advisory Board.
Olive Garden, KFC, and Shake Shack look like particularly appetizing investments in 2025, according to Oppenheimer analysts.
It's a new year, and with that, the 2025 S&P 500 forecasts from the big names on Wall Street are in.
NEW YORK , Oct. 15, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — announced today that Christian Baetz joined the firm as a Managing Director in the firm's Consumer Investment Banking Group. He will be based out of Oppenheimer's New York office and report to Michael Cella, Managing Director and Group Head of U.S. Consumer Investment Banking.
SEATTLE, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, today announced that its senior management will participate in panel discussions and company presentations at the Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology Summit in New York, NY on October 8, 2024 and the JonesResearch Virtual Radiopharma Day on October 29, 2024.
Industry Veteran to Bring His Experience Leading, Attracting, and Retaining Advisors to His New Location NEW YORK , Oct. 1, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") – a leading wealth manager, investment bank, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) – today announced that Todd Wiggins has been named the Regional Director of its Dallas-Fort Worth Region. Wiggins joined Oppenheimer in 2016 and has served as Managing Director of Investments and Branch Manager in the firm's Atlanta office.
Latest Move into Tennessee Builds on Firm's Momentum Following the Opening of Its Nashville Office in 2022 NEW YORK , Sept. 23, 2024 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer) — a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE: OPY) — today announced the opening of its new office in Memphis, Tennessee, along with the recruitment of Alan Richmond, Executive Director – Investments, and Clayton Ellis, Director – Investments.
Brian Nagel, Oppenheimer & Co. senior analyst, joins CNBC's 'Power Lunch' to discuss what Nike's leadership change could mean for the company, the path forward for the stock, and more.